UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 13, 2015
Shire plc
(Exact name of registrant as specified in its charter)
Jersey, Channel Islands
(State or other jurisdiction of incorporation)
0-29630 | 98-0601486 |
(Commission File Number) | (IRS Employer Identification No.) |
5 Riverwalk, Citywest Business Campus, Dublin
24, Republic of Ireland
(Address of principal executive offices) | (Zip code) |
Registrant's telephone number, including area code | +353 1 429 7700 |
(Address of principal executive offices) (Zip code)
Registrant's telephone number, including area code +353 1 429 7700
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.f13e-4(c))
Item 8.01. | Other Events |
Shire plc have issued the press release attached hereto as Exhibit 99.1 which is incorporated by reference herein.
Item 9.01. | Financial Statements and Exhibits |
(d) Exhibits. The following exhibit is filed herewith:
99.1 | Press Release dated October 13, 2015 |
2 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
SHIRE PLC | ||||
By: | /s/ B Mordan | |||
Name: | Bill Mordan | |||
Title: | Company Secretary |
Dated: October 16, 2015
3 |
EXHIBIT INDEX
Number |
Description |
99.1 | Press Release dated October 13, 2015 |
Exhibit 99.1
Press Release | ![]() |
www.shire.com |
Shire to announce third quarter 2015 results
Dublin, Ireland – October 13, 2015 – Shire plc (LSE: SHP, NASDAQ: SHPG), will announce third quarter 2015 earnings on Friday October 23, 2015.
Results press release will be issued at: | 12:00 BST / 07:00 EDT |
Investor conference call time: | 14:00 BST / 09:00 EDT |
Live conference call for investors:
Flemming Ornskov, Chief Executive Officer and Jeff Poulton, Chief Financial Officer will host the investor and analyst conference call at 14:00 BST/9:00 EDT.
The details of the conference call are as follows:
UK dial in: | 0808 237 0030 or 020 3139 4830 |
US dial in: | 1 866 928 7517 or 1 718 873 9077 |
International Access Numbers: | Click here |
Password/Conf ID: | 25841912# |
Live Webcast: | Click here |
Replay:
A replay of the presentation will be available for two weeks by phone and by webcast for three months. Details can be found on our Investor Relations website http://investors.shire.com/.
For further information please contact:
Investor Relations | ||
Matthew Osborne | mattosborne@shire.com | +1 781 482 9502 |
Sarah Elton-Farr | seltonfarr@shire.com | +44 1256 894157 |
Notes to editors
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.
We focus on providing treatments in Rare Diseases, Neuroscience, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmics.
www.shire.com
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX
#K]P?2O:-"N[>S\):?-&7O
MFN26 A*'-2E<[89E4C4Y:L;'J^LPZ!+/&=7%J90OR>